Credit Suisse maintains underperform rating on the stock as its operational outlook remains weak across segment. Petchem input costs of GAIL in Q2 remained high and utilisations were lower than expected, the segment posted its third consecutive quarter of EBITDA loss.
| Subscribe To Our Free Newsletter |
